Reuters logo
BRIEF-Novo Nordisk says Semaglutide receives positive 16-0 vote in favour of approval from FDA advisory committee​
October 18, 2017 / 9:35 PM / a month ago

BRIEF-Novo Nordisk says Semaglutide receives positive 16-0 vote in favour of approval from FDA advisory committee​

Oct 18 (Reuters) - Novo Nordisk A/S

* Semaglutide receives positive 16-0 vote in favour of approval from FDA advisory committee​

* EMDAC of US FDA voted 16-0 in favour of approval of Semaglutide to improve Glycaemic control in adults with Type 2 diabetes​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below